N-(1-((1H-indol-5-yl)methyl)piperidin-4-yl)-7-fluoro-4-oxo-4H-chromene-2-carboxamide

ID: ALA216180

Chembl Id: CHEMBL216180

PubChem CID: 11589812

Max Phase: Preclinical

Molecular Formula: C24H22FN3O3

Molecular Weight: 419.46

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NC1CCN(Cc2ccc3[nH]ccc3c2)CC1)c1cc(=O)c2ccc(F)cc2o1

Standard InChI:  InChI=1S/C24H22FN3O3/c25-17-2-3-19-21(29)13-23(31-22(19)12-17)24(30)27-18-6-9-28(10-7-18)14-15-1-4-20-16(11-15)5-8-26-20/h1-5,8,11-13,18,26H,6-7,9-10,14H2,(H,27,30)

Standard InChI Key:  RAUHDNCAWVVITH-UHFFFAOYSA-N

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCHR1 Tchem Melanin-concentrating hormone receptor 1 (5587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCHR2 Tchem Melanin-concentrating hormone receptor (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin Melanin-concentrating hormone receptor 2/HERG (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 419.46Molecular Weight (Monoisotopic): 419.1645AlogP: 3.81#Rotatable Bonds: 4
Polar Surface Area: 78.34Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.87CX LogP: 2.71CX LogD: 2.11
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.53Np Likeness Score: -1.24

References

1. Iyengar RR, Lynch JK, Mulhern MM, Judd AS, Freeman JC, Gao J, Souers AJ, Zhao G, Wodka D, Doug Falls H, Brodjian S, Dayton BD, Reilly RM, Swanson S, Su Z, Martin RL, Leitza ST, Houseman KA, Diaz G, Collins CA, Sham HL, Kym PR..  (2007)  An evaluation of 3,4-methylenedioxy phenyl replacements in the aminopiperidine chromone class of MCHr1 antagonists.,  17  (4): [PMID:17234405] [10.1016/j.bmcl.2006.11.065]

Source